Trials / Completed
CompletedNCT03535571
A Study to Evaluate the Efficacy of Salmon Protein Hydrolysate Powder on Energy Increase and Anti-inflammatory Modulation in Healthy Males and Females
A Proof-of-concept Study to Evaluate the Efficacy of Salmon Protein Hydrolysate Powder on Energy Increase and Anti-inflammatory Modulation in Healthy Males and Females
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Hofseth Biocare ASA · Industry
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the efficacy of Salmon Protein Hydrolysate Powder (CollaGo®) on energy increase and anti-inflammatory modulation in healthy males and females. Eligible participants will be asked to consume 1 sachet of CollaGo for 128 days and keep a study diary. Assessments will be measured at the randomization visit, and the end of study visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Salmon Protein Hydrolysate | 4g of salmon protein hydrolysate per serving. |
Timeline
- Start date
- 2018-06-05
- Primary completion
- 2018-10-23
- Completion
- 2018-10-23
- First posted
- 2018-05-24
- Last updated
- 2019-08-19
- Results posted
- 2019-08-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03535571. Inclusion in this directory is not an endorsement.